Here's the realityMedreleaf CXO's stepped away from the table during integration and essentially got/getting out of their stock positions altogether. There will be a huge number of available ACB shares during the next stretch. This will cause uncertainty until a press release for an institutional stock lock-down is announced. It would also be of big benefit if Aurora announced the leadership team with some new strong personnel. In the meantime, this is day one after finalizing the merger, so patience is needed. The price will come back next week then lower to around $7.80 on Friday. There will likely be another drop off 2 weeks into August. The number of shareholders is obviously the biggest concern, but the stock is worth more than this mornings trade value.